GCN2 Antikörper (AA 1401-1500)
EIF2AK4
Reaktivität: Human
WB, ELISA
Wirt: Maus
Polyclonal
unconjugated
-
-
Target
Alle GCN2 (EIF2AK4) Antikörper anzeigen
-
GCN2 (EIF2AK4)
(Eukaryotic Translation Initiation Factor 2 alpha Kinase 4 (EIF2AK4))
-
Bindungsspezifität
-
AA 1401-1500
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser GCN2 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA
-
Verwendungszweck
-
Mouse polyclonal antibody raised against a partial recombinant EIF2AK4.
-
Sequenz
-
VVSVGQMSMS RAINLTQKLW TAGITAEIMY DWSQSQEELQ EYCRHHEITY VALVSDKEGS HVKVKSFEKE RQTEKRVLET ELVDHVLQKL RTKVTDERNG
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody Reactive Against Recombinant Protein.
-
Immunogen
-
EIF2AK4 (NP_001013725, 1401 a.a. ~ 1500 a.a) partial recombinant protein with GST tag.
-
Top Product
-
Discover our top product EIF2AK4 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Buffer
-
50 % glycerol
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Target
-
GCN2 (EIF2AK4)
(Eukaryotic Translation Initiation Factor 2 alpha Kinase 4 (EIF2AK4))
-
Andere Bezeichnung
-
EIF2AK4 (EIF2AK4 Produkte)
-
Synonyme
-
EIF2AK4 antikoerper, Gcn2-like antikoerper, GCN2 antikoerper, 2610011M03 antikoerper, MGCN2 antikoerper, eukaryotic translation initiation factor 2 alpha kinase 4 antikoerper, eukaryotic translation initiation factor 2-alpha kinase 4 antikoerper, eIF-2-alpha kinase GCN2 antikoerper, EIF2AK4 antikoerper, LOC579979 antikoerper, LOC100187226 antikoerper, eif2ak4 antikoerper, Eif2ak4 antikoerper
-
Hintergrund
-
Full Gene Name: eukaryotic translation initiation factor 2 alpha kinase 4
Synonyms: GCN2,KIAA1338
-
Gen-ID
-
440275
-
NCBI Accession
-
NM_001013703
-
Pathways
-
ER-Nucleus Signaling, Hepatitis C
-